International journal for parasitology: drugs and drug


Types of articles considered



Yüklə 150,22 Kb.
Pdf görüntüsü
səhifə2/19
tarix01.06.2022
ölçüsü150,22 Kb.
#88498
1   2   3   4   5   6   7   8   9   ...   19
2211-3207

Types of articles considered:
Compound library screening for inhibitors against enzymes or whole
parasites Drug target validation (chemical and/or genetic) Drug target identification (must include
some inhibitor studies rather than characterisation of an enzyme, for example)Drug structure-activity
relationship studies Mechanisms of drug action and resistanceReports of the development of drug
resistance both in the field and laboratory Studies on drug toxicity to the host (either on single host
cells or whole organism) Reports on toxicity in the field Computational approaches to drug discovery or


AUTHOR INFORMATION PACK 26 May 2022
www.elsevier.com/locate/ijpddr
2
drug-target identification Development of assays directed at screening for inhibitors Drug combination
studies Natural products as anti-parasitic agents Bioactive products produced by parasites Use of
live parasites as immunomodulatory agents Epidemiological aspects of the emergence and spread of
parasite drug resistance Human clinical trials
The other specialist title in the series is 
International Journal for Parasitology: Parasites and Wildlife
.
AUDIENCE
.
Parasitologists, Zoologists, Entomologists, schools of tropical medicine.
IMPACT FACTOR
.
2020: 4.077 © Clarivate Analytics Journal Citation Reports 2021
ABSTRACTING AND INDEXING
.
Google Scholar
ScienceDirect
Scopus
PubMed Central
Science Citation Index
Directory of Open Access Journals (DOAJ)
EDITORIAL BOARD
.
Editors in Chief
Andrew Kotze
, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Queensland Bioscience
Precinct, St Lucia, Australia
Kevin Saliba
, The Australian National University, Research School of Biology, Acton, Australia

Yüklə 150,22 Kb.

Dostları ilə paylaş:
1   2   3   4   5   6   7   8   9   ...   19




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©genderi.org 2024
rəhbərliyinə müraciət

    Ana səhifə